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ABSTRACT 
In 2006, a ban on the use of antibiotics was implemented in Europe which has resulted in 
an increase interest in finding alternatives to therapeutic use of antibiotics in swine industry.  
Thus, we hypothesize that feeding sows probiotics during gestation and lactation could 
potentially improve health and well-being of not only sows but her piglets’ as well.    The 
objectives of this study were to: (a) evaluate the effects of feeding a bolus of yeast 
Saccharomyces boulardii (yeast probiotic) to sows during gestation and lactation on her behavior 
and well-being as well as her piglets’ well-being, and (b) assess the effects of weaning stress on 
piglets from sows that were fed probiotics. At d 84 of gestation, 18 sows derived from 
Genetiporc maternal line across 3 blocks (6 sows/block) were randomly allotted to receive either 
a placebo bolus (control; CON) or probiotic bolus (treatment, PRO) once per day till the end of 
lactation. The probiotic bolus used was composed of a monogastric-specific yeast produced by 
LALLEMAND, known as LEVUCELL SB® (Saccharomyces boulardii CNCMI-1079).  Data 
were collected to assess behavioral, physiological, and performance traits of sows and piglets.  
Data were analyzed using the Mixed Models procedure of SAS.  Sows fed PRO bolus had higher 
(P < 0.01) white blood cell counts compared to sows fed CON bolus.  On d115 of gestation, 
sows fed PRO bolus had higher (P < 0.05) level of total white blood cell and neutrophils 
compared to sows fed CON bolus.  On day of weaning (~d135 of experimental period), plasma 
cortisol was less (P < 0.05) among sows fed PRO bolus compared to sows fed CON.  At birth, 
those piglets from sows fed PRO bolus had less (P < 0.01) total plasma cortisol compared to 
those piglets from sows fed CON bolus.  Piglets from sows fed PRO bolus had higher (P < 0.05) 
white blood cell counts overall during lactation compared to piglets from sows fed CON.  On d7 
of age, those piglets from sows fed PRO bolus had less (P < 0.05) neutrophils (%) but more (P = 
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0.057) lymphocytes (%) compared with those piglets from sows fed CON bolus.  The results of 
this study indicate that probiotics may have beneficial effects on both sow and piglet behavior 
and well-being.  Future research should continue to compare various aspects of yeast-like 
products that may have potential physiological effects on immune status, behavior and 
productivity of sows and their offspring, thus improving well-being.   
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CHAPTER 1 
LITERATURE REVIEW 
 
1.1 Introduction 
 There is mounting concern among the public and consumers on the use of prophylactic 
antibiotic use in food production not only on human health but food safety and animal well-
being.  In 2006, the European Union implemented restrictions of the therapeutic use of 
antibiotics in production animals and in 2012 the FDA proposed a voluntary phase out of the use 
of antimicrobials that are medically important in human medicine in animal production.  Because 
of these new concerns and regulations, there has been an increased interest in the use of 
probiotics as a potential alternative to therapeutic use of antibiotics in food animals.  Hundreds of 
clinical studies have shown beneficial health effects of consuming bacterial and yeast derived 
probiotic in humans.  In 2007, Yoplait first introduced “Activia” a probiotic supplemented 
yogurt that if consumed could “help to regulate the digestive system” in humans.  Hence, 
consumers are demanding more natural, holistic products.  With this increase in demand it is 
important that we continue to research the possible advantages and disadvantages of probiotic 
use in our production animals. 
1.2 What are Probiotics and How Do They Work 
According to the Webster dictionary, probiotics are defined as ‘pertaining to life’.   More 
specifically, ANTIbiotics are a compound that kills an organism that has been encountered 
within the body, while PRObiotics is a substance that increases microbial organisms of the gut 
flora.  Hence, instead of controlling the amount of bacteria in the gut, probiotics increase the 
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number of beneficial microbes so that once the infection occurs the body naturally fights off the 
pathogens without the assistance of antibiotics.  In order for a probiotic supplement to be 
effective it must  express certain charateristics—probiotics must survive the passage through the 
acidic gastrointestinal tract, be able to colonize and reproduce in the gut, and adhere to the 
intertinal epithelium while stabilizing the balance of the gut flora (Drisko et. al 2005). 
 
1.3 Classes of Probiotics  
Probiotics can be either of bacterial or yeast orgin.  The most common species used to 
produce probiotics are Acidophilus, Bacillus, Lactobacillus, Bifidobacterium, Streptococcus, and 
Saccharomyces with the most studied probiotics being derived from  Lactobacillius and 
Bifidobacterium (Latic Acid Bacteria; LAB) and Saccharmoyces boulardii (Weichselbaum, 
2009).  The LAB  probioitc is a natural flora found in the gut while S. boulardii is a beneficial 
supplement.  Lactobacillus, found in the small intestine, and Bifidobacterium, found in the large 
intestine, are known as lactic acid bacteria because they produce lactic acid as a byproduct.  The 
LAB help maintain a healthy balance of intestinal flora by producing compounds such as; lactic 
acid, hydrogen peroxide, and acetic acid which all increase the acidity of the intestine and curb 
the reproduction of harmful bacteria. The human body is dependent upon these normal bacteria 
to help break down food, aid in nutrient absorption, and prevent the take-over of “bad” bacteria 
within the body.  Morever, these bacterial probiotics need support from other supplements, such 
as prebiotics, to survive the passage through the stomach and intestine. Despite the benefits of 
these various species they can also be detrimental if gut homeostasis is not maintanied, 
especially during stress and illness.  
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S. boulardii, was first discovered by Henri Boulard in the year 1920 in Indochina.  This 
yeast derived probiotic had different properties than a bacterial derived probiotic. Unlike the 
common “bad” yeast we usually encounter, S. boulardii commonly known as “baker’s yeast” is 
non-pathogenic but does not naturally occurr in the gut like the bacterial probioitics.  However, 
Sacchromyces is resisitant to stomach acids, bile and pancreatic juices which makes it tolerant to  
varying pH levels and thermotolerant.  Hence, these protective properties  Sacchromyces 
increase survivability of this organism while moving through the gut.  In contrast to other 
probiotics, Sacchromyces is resistant to antibiotics (Czerucka et al., 2007) and S. boulardii does 
not colonize in the gut and has been shown to be removed from the body and stool within 2 to 5 
days after discontinuing use (Czerucka and Rampal, 2002). 
 
1.4 Possible Mechanisms 
Numerous studies have been conducted to determine the effects of various strains and 
combinations of bacterial and yeast probiotics on health and disease while the precise 
mechanism is largely unknown.  Possible mechanisms by which probiotics may affect the host 
gastrointestinal system and overall immune functions have been proposed (see Figure 1).  Servin 
and Coconnier (2003) found that Lactobacillus inhibits the adhesion of the S. typhimurium while 
supernatants from L. johnsonii has been shown to interfere with the growth and adhesion of the 
of H. pylori in the gut.  S. boulardii, has been shown to bind pathogens such as C. difficile, which 
deactivates the bacteria and inhibits attachment to the epithelium (Czerucka and Rampal, 2002).  
Giang et al., (2010b) found that S. boulardii can inhibit toxicity of E.coli extracellular endotoxins 
by restricting binding to enterocyte receptors but had no effect on actual E.coli counts.  Also, S. 
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boulardii secretes a protease that can degrade Toxins A and B produced by C. difficile. Lactic 
acid, a substance produced by probiotics, has deleterious properties towards many 
microorganisms and can produce antibacterial properties (Marteau et al., 2004).  S. boulardii has 
been shown to increase the concentration of short-chain fatty acids, lactic acid bacteria (LAB) 
population and lactic acid levels. An increase in VFA in the colon increases water and sodium 
absorption in the lumen and could decrease scouring during an E.coli infection (Giang et al., 
2010a).  The increased content of organic acids facilitated by S. boulardii would acidify the 
intestine and exert an antibacterial effect.  Probiotics have the ability to enhance the defenses of 
the mucosal system. The GALT contains mucus gel which helps protect the intestinal mucosa 
from the luminal environment.  Mack et al., (1999) found that L. plantarum and L. rhamnosus 
both can upregulate mucosal gel and inhibit the adherence of E. coli to the intestinal epithelial 
cells. The intestinal permeability is a key factor in pathogenesis of many mucosal diseases.  
Several trials have shown that probiotics may protect tight junctions from becoming leaky during 
infectious or inflammatory conditions.  L. brevies and L. plantarum (Marteau and Boutron-
Ruault, 2002) and S. boulardii (Czerucka et al., 2000) have all been shown to reduce the 
increased intestinal permeability during E. coli infection.   
There is also some evidence that suggest probiotics can nonspecifically modulate the host 
immune system. The immune system is comprised of innate and adaptive immunity (Figure 2).  
The innate immune response primarily involves phagocytic cells, while the adaptive immune 
response involves T- (cell mediated immunity) and B- cells (humoral immunity) and appropriate 
cytokines need to be present to result in the appropriate immune response.  More specifically, T-
helper 1 (Th1) cells produce IL-2, interferon-y (IFN-y) and Tumor Necrosis Factor-alpha (TNF-
α), whereas T-helper 2 (Th2) cells produce IL-4, IL-5, IL-6, IL-10 and IL-13(Figure 3).  
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Probiotics may promote the nonspecific stimulation of the host immune system such as enhanced 
phagocytic activity since this is the first line of defense against bacterial challenges.  In fact, 
bacterial probiotics such as Lactobacillus have repeatedly been shown to increase the rate of 
phagocytosis in the host (Klein et al., 2007; Olivares et al., 2006; Roessler et al., 2008).  
However, probiotics have been shown to have immunosuppressive properties by suppressing the 
inflammatory response most likely through disrupting levels of the pro- and anti-inflammatory 
cytokines.  Specifically, S. boulardii has been shown to block the secretion of inflammatory 
cytokines such as IL-8, IL-6 and TNFα which are released in response to an infection (Dahan et 
al., 2003; Dalmasso et al., 2006a), whereas, Bifidobacteria and Lactobacillus have been shown 
to have no effect on TNFα.  Olivares et al. (2007) reported an increase in plasma IL-12 in 
healthly adults when they received supplements with L. gasseri  but Taylor et al., (2006) reported 
no effect when  L. acidophilus supplements were used.  Others have shown that the B-cell 
population in the duodenum increased after the adminstration of bacterial probiotic L. reuteri 
(Valeur et al., 2004), while intramucosal gut T-cells and IgA levels in the intestine have been 
shown to increase in healthy adults given S. boulardi derived supplements.  
 
1.5 Bacterial Probiotic Effect on Humans 
 The human body contains between 1012   and 10 14 of bacteria with the majority of these 
conlonizing in the gut starting at birth.  These bacteria are vital for a healthy immune system to 
fight against the invasion of pathogenic strains, aid in digestion, and to assit in releasing vitamins 
and nutrients.  Of these numerous strains, only a select few are culturable, which can potentially 
benefit the health of an individual by modulating the gut flora and aiding in these processes. 
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However, different  strains, mixtures of strains, and delivery systems (i.e, yogurt, powder) can 
result in different benefits.  The most commonly researched bacterial probiotic is Lactobacilius 
rhamnosus GG (LGG) and Bifidobacterium.  Both, Szajewska et al., (2001) and D'Souza et al., 
(2002) found that LGG could reduce the number of cases of a Antibiotic-associated diarrhea 
(AAD) in children that were receiving Aminopenicillin therapy.  Of course, specific strains do 
vary in effectivness in treating diseass.  For example, researchers found that L. rhamnosus 
decreased symptoms associated with irritial bowel syndrome (IBS) (Gawrońska et al., 2007), 
whereas others found that Lactobacillus johnsonii had no affect on the occurrence rate of 
diaharrea in their patients (Marteau et al., 2006; Van Gossum et al., 2006).  Moreover, Hickson 
et al., (2007) found that a combination of several bacteria (L. casei, L. thermophilius, and L. 
bulgarious) mixed in yogurt could reduce the risk of C. difficile associated diahrrea and none 
none of these patients developed AAD even though 9 out of 17 (52.0%) of these patients were 
positive for C. difficle toxin.  It appears that a combination of different probiotics may be more 
beneficial over a single strain, several reseachers have reported that combining 8 different 
bacterial strans (VSL#3) relieved the symptoms associated with Colitis and IBD (Kim et al., 
2003; Venturi et al., 1999).  In fact, Venturi et al. (1999) reported that 75% of these patients were 
still in remission 12 months post-treatment.  Although the results vary from strain-to-strain these 
data  provide support that there are health benefits associated with using probiotic supplements.    
 
1.6 Bacterial Probiotic Effects on Piglets 
 In 1970, Zimmerman et al., (1970) first studied the effects of challenging germ-free rats 
with microorganisms on the immune system.  Today, researchers have broadened the scope  to 
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include other species such as humans, dogs, livestock, and aquatic species (i.e., farm-raised fish). 
The public interest and demand for antibiotic-free products has led to an increase in studying the 
effects of using probiotic supplements in the livestock industry as a potential alternative to 
antibiotics as growth promotants.  The most commonly used probotics are bacterial derived 
species that come from either the genus of Bacillus or Streptococcus.  Giang et al., (2010a) found 
that those piglets fed LAB had reduced incidence of diarrhea and improved average daily feed 
intake (ADFI), average daily gain (ADG) and lower feed conversion ratio (FCR) than did piglets 
in the control group.  Moreover, a mixture of both Bacillus and Steptococcus tended to enhance 
ADG and FCR in piglets subjected to weaning and mixing stress (Taras et al., 2005).  Following 
an E. coli challenge, those piglets feed a supplement of Lactobacilius rhamnosus GG (LGG) had 
a lower incidence rate of diarrhea as well as increased serum TNFα but decreased IL-6. Total 
intestinal IgA has been shown to be increased by Bidifobacterium longum (Vitini et al., 2000). 
During lactation, serum levels of IgG were not affected by Enterococus faecuim, but post-
weaning serum levels of IgG were stabilized for piglets fed E. faecuim compared to controls.  
Others have effects of LGG on the immune system of piglets.  Collado et al., (2007) found that 
LGG could adhere to intestianl mucus in vitro and displace as well as inhibit Salmonella, 
Colostridum, and E. coli, while Zhang et al. (2010) found that LGG affected various pro- and 
anti-inflammatory cytokines but had no effect on total white blood cell count. 
 
1.7 Bacterial Probiotics Effects on Sow and Offspring  
 Bacterial probiotics fed to sows may potentially benefit not only the sow but her 
offspring too.  Feed intake during lactation (5.2 vs. 4.2 kg/d) was increased in sows fed Bacillus 
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cereus var. toyoi probioitc and body weight loss was less post-lactation compared to control fed 
sows (Taras et al., 2005).  Others have shown that feed intake was increased in sows fed 
Enterococcus faecium and body weight loss throughout lactation was less and these sows had 
increased litter size (Kreuzer and Zerhusen et. al., 1995; Bohmer, 2006).  Also,  fecal E.coli 
count and body temperature were lower amongst sows fed E. faecium compared to control sows 
(Bohmer, 2006).  Bohmer attributes the effect on body temperature to the enhancement of the 
immune system when dealing with the stressors associated with farrowing.  Also, feeding sows  
B. cereus led to an increase in fecal IgA during lactation (Scharek et al., 2005).  Moreover, 
BioPlus2B, a probiotic which contains  Bacillus lincheniformus and Bacillus subtilis, when fed 
to sows resulted in a decrease in preweaning mortality, diarrhea occurrence, and increase in 
percentage of fat in the milk during mid-suckling period (Alexopoulos et al., 2004).  Moreover, 
sows fed BioPlus2B weaned more pigs and piglets from those sows fed BioPlus2B had greater 
body weight. 
 
1.8 Sacchromyces boulardii Effect on Health 
Most of the research using S. boulardii as the primary probiotic has been conducted in 
humans and rodents.  It has been shown that this specific strain can control diarrheal disease in 
rats and humans, but its precise mechanisms are not known (Buts, 2009).  Moreover, others have 
shown that S. boulardii can reduce symptoms of IBD, such as Crohn’s, colitis, and prevent or 
treat diarrheal diseases such as AAD, acute  gastroenterisitis,  and chronic diarrhea in human 
immunodeficiency virus-infected patients.  
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1.9 Saccharomyces boulardii Effect on the Immune System 
In both humans and swine, yeast probiotics can cause the proliferation of LAB which has 
an effect on inflammation in the intestinal tract.  The proliferation of LAB in the intestine leads 
to the secretion of immunosuppressive cytokines, such as interleukin-10 (IL-10) (De Moreno de 
LeBlanc et al., 2008).  This LAB induced-secretion of IL-10 results in an “anti-TNFα” effect in 
the intestine and IL-10 crosses the intestinal barrier to reach the local immune system under both 
normal and inflammatory conditions (Perdigon et al., 2002).  Lactic acid bacteria enhances the 
non-specific and specific immune responses, helping to control intestinal infections, mainly 
through control of  TNFα, (Dalmasso et al., 2006b), whereas, others have reported no effect of S. 
boulardii on the production of various cytokines such as IL-6, IL-10, IL-12p70, IL-23 and TNFα  
(Gad et al., 2011).  S. boulardii  has been shown to improve the condition of the intestinal barrier 
by decreasing lipopolysaccharide (Thomas et al., 2011), preventing the adherence of pathogens 
to the intestinal wall, and neutralizing bacterial endotoxins (Gad et al., 2011).  These minor 
effects positively affect the intestinal system which in turn aids the immune response.   These 
indirect effects are one reason why S. boulardii is such a good candidate against intestinal upsets. 
 
1.10 Sacchromyces boulardii Effect on Swine 
One of the most common yeast probiotics investigated has been S. boulardii due to its 
positive effects in humans. Breves et al. (2000) found that supplementing a swine diet with B. 
cereus var. toyoi and S. boulardii increased sodium-dependent glucose absorption and trans-
epithelial nutrient transport in the jejunum. Others have found that feeding S. boulardii led to an 
increase in the villous length in the small intestine of pigs (Kamm et al. (2004).  Both,(Gad et al., 
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2011; Perdigón et al., 2002) reported a reduction in pathogen-induced diarrhea amongst piglets 
fed a S. boulardii supplement compared to piglets without the supplement. Often weaning stress 
can result in the breakdown of the intestinal barrier function as detected by a decrease in villous 
height and nutrient absorption.  Le Bon et al. (2010) found that feeding S. boulardii to piglets for 
6 weeks then feeding Pediococcus acidilatici for the next 3 weeks led to an increase in the feed 
conversion ratio of piglets, most likely by decreasing the E.coli population, when compared to 
control pigs.  Others have found that S. boulardii can inhibit toxicity of E.coli extracellular 
endotoxins by restricting the binding to enterocyte receptors but had no effect on actual E. coli 
count (Giang et al., 2010a).  Supplementing swine weaning diets with S. boulardii may be 
extremely beneficial especially since the stress of weaning can cause the decrease in good 
bacteria while increasing the  E.coli population which contributes to increased susceptibility to 
illness and health (Giang et al., 2010b).   
 
1.11 Maternal Behavior and its Effect on Piglet Well-being 
 Sow behavior during farrowing and lactation can be useful indicators of well-being. Pre- 
partum nest-building, post-partum duration in specific postural position and responsiveness to 
piglets expressed by the sow are very important for piglet survival throughout the lactation 
phase.  Nest-building behavior is initiated around parturition due to the rise in prolactin and the 
drop of progesterone (Wischner et al., 2010). In confinement, nest building starts with sows 
digging or pawing with the front hooves (Algers and Uvnas-Moberg, 2007) but in the wild, sows 
dig in order to create a hole and will rip and gather branches and grass to fill the nest and 
distribute evenly. In confinement, often nest-building behaviors are displayed by sows biting and 
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pulling at the rails, pipes, waterer, and feeder with nodding head movements while rubbing their 
snout against the floor since these environments are devoid of actual physical nesting material 
(Lou and Hurnik, 1998).  Sows that perform a greater amount of nest-building behaviors have 
been shown to respond better to stimuli expressed by piglets and overall have better performance 
(Algers, 1994). One of the leading causes of death in the first 72-h of life for a piglet is crushing.  
In the first few days of life piglets are unable to regulate their own body temperature. According 
to Hrupka et al. (1998), regardless of heat lamp location or air temperature piglets tend to lie next 
to the sow.  The sow’s pre-lying behavior and postural changes are very important for piglet 
safety due to their proximity to the sow.  Research has shown that sows who sit first before lying 
down tend to crush more piglets (Wischner et al., 2009) while sows that tend to stay in one 
position for a longer period of time have improved maternal ability and increased piglet well-
being (Cui et al., 2011).  Staying in one position longer allows piglets to move closer to the 
udder for nutrients but also allows for a warm and safe environment.  When Wischner et al. 
(2010) evaluated crushing rates of piglets by sows, they found those sows that displayed longer 
durations and more frequent bouts of standing and less sitting were less likely to crush their 
piglets. 
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CHAPTER 2 
A PILOT STUDY ON THE EFFECTS OF PROBIOTICS ON SOW AND PIGLET 
BEHAVIOR AND WELL BEING 
INTRODUCTION 
 
Antibiotics are routinely used in healthy production animals to improve feed efficiency 
and sustain healthy animals. However, the use of antibiotics in food animals has become a global 
concern due to the increased occurrence of antibiotic resistant bacteria.  Hence, this has led to an 
increasing interest in finding an alternative to antibiotics, such as probiotics. Probiotics are 
microorganisms that, when ingested in adequate amounts, confer a health benefit on the host 
(Czerucka et al., 2007).  Probiotics have been shown to improve intestinal microbial balance, 
thus inhibiting pathogens and toxin-producing bacteria. Recently it has been shown that feeding 
probiotics to piglets during lactation enhances animal well-being by reducing the incidence of 
pathogen-induced diarrhea post-weaning (Gad et al., 2011).  If the benefits of probiotics are 
transferable from dam to piglets, the benefits of feeding the dam probiotics during gestation and 
lactation may outweigh the economic cost of the addition of the supplement to daily feed of 
wean-to-finish pigs.  The goal of this research was to evaluate the effects of feeding a yeast 
probiotic, Saccharomyces boulardii, to sows during gestation and lactation on sow and piglet 
behavior and well-being and to evaluate how weaning stress may differentially affect the well-
being of piglets from sows that were fed probiotics during gestation and lactation.   
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MATERIALS AND METHODS 
Animals, Housing, and Experimental Design 
   Eighteen sows derived from the Gentiporc maternal line were kept at the University of 
Illinois Swine Research Center and housed in standard gestation stalls in a mechanically-
ventilated insulated gestation building until ~d 112 of gestation.  All diets were formulated to 
meet or exceed NRC requirements (NRC, 2012; Table 3.2).  Sows were fed once daily during 
gestation based on body condition score.  At d112 sows were moved to farrowing rooms and 
kept in individual farrowing stalls and maintained on a 10:14 h light:dark schedule with lights on 
at 0700 h and lights off at 1700 h.  During lactation sows were fed ad libitum.  On d 84 of 
gestation, sows were allocated to either a placebo bolus (CON) or probiotic bolus (PRO) based 
on body weight (BW) (n = 18 sows, 9 sows per treatment). The probiotic bolus was composed of 
monogastric specific yeast produced by LALLEMAND, known as LEVUCELL SB® 
(Saccharomyces boulardii CNCMI-1079).  The concentration of each bolus was 2.0 x 
109(CFU/g).  Levucell SB is non-toxic and harmless to humans and animals.  It leaves no 
residues and has no withdrawal time.   
Starting on d84 of gestation, sows were hand-fed 2 boluses every morning around 0600 h 
(feeding time) until the end of lactation (weaning ~ d 21 of lactation).  The CON bolus was 
always fed first.  Gloves were worn and discarded and hands were washed after the daily feeding 
of the probiotics bolus, to prevent the possible transfer of probiotics to the control-fed sows. The 
CON bolus was sugar based and was the same size and shape of the PRO bolus.   
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Physiological Measures 
Blood samples (~10 mL) were obtained from sows on d 84, 91, 98, 112 of gestation, 24-h 
post-farrowing and weaning via vena-puncture using vacutainers.  Blood samples (~10 mL) were 
obtained from piglets on d 0 (immediately after birth), 1 (pre-process and post-process), 7, 14, 
and 21 of age (weaning), and then again at 24 h post-weaning and on d 7, and 14 post-weaning.  
Red blood cells were lysed with Zap-o-globin® (Beckman Coulter) and total white blood cell 
counts (WBC) were made electronically using a Coulter Z1 particle counter (Beckman Coulter) 
by adding 10μL of whole blood to Isoflow® (10 mL; Beckman Coulter, Miami, FL).  Whole 
blood smears were made, fixed in methanol, stained with Hema-3® staining system (Fisher 
Scientific, Houston, TX) and viewed under a light microscope to determine leukocyte differential 
counts (Figure 1a). 
For functional immune assays, whole blood was diluted with Roswell Park Memorial 
Institute medium (RPMI; Gibco, Carlsbad, CA) layered over Histopaque® -1077, (density = 
1.077 g/mL; Sigma Aldrich, Saint Louis, MO) and -1119 (density = 1.119 g/mL; Sigma Aldrich) 
and centrifuged at 700g 30 min at 25°C.  Lymphocytes were removed from the 1077 layer, 
washed twice in RPMI, resuspended, and counted.  Neutrophils were removed from the 1119 
layer, washed once, and then red blood cells were lysed from the neutrophil fraction, and washed 
again in RPMI (Figure 1b).  Cell concentrations were adjusted with RPMI based on the specific 
immune assays’ respective requirements.  
Plasma Analysis 
 Whole blood was collected and centrifuged at 700g for 30 min at 4°C to collect plasma 
for analysis.  Using a validated commercial radioimmunoassay (Coat-A-Count®, Los Angeles, 
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CA) plasma cortisol concentrations were measured. Intra- and inter-assay CV were 4.5% and 
5.6%, respectively.  Using a Quantikine Porcine IL-12/IL-23 p40 Eliza kit (R&D Systems® 
Minneapolis, MN), sow and piglet plasma samples were measured for levels of IL-12.   
Immune Assays 
  Neutrophil Chemotaxis was measured using an assay previously described by (Salak et 
al., 1993). Neutrophils were used at a concentration of 3 × 106 cells/mL to evaluate the ability of 
cells to migrate toward assay medium (control; random migration) or recombinant human 
complement-5a (10−7 M; Sigma Aldrich) and recombinant human IL-8 (100 µg/mL; Sigma 
Aldrich) (chemotaxis-directed migration).  
 Neutrophil phagocytosis was measured using a flow cytometry-based assay as previously 
described by (Jolie et al., 1999) with minor modifications as described by (Niekamp et al., 2006).  
Fluorescent beads were pre-incubated for 30 min with heat-inactivated porcine serum before 
adding beads to the samples at a 10:1 (beads-to-neutrophils) ratio and then cells and beads were 
incubated for 45 min at room temperature. The percentage of beads engulfed by cells was 
evaluated using a flow cytometry. 
 A mitogen-induced lymphocyte proliferation assay was performed using a CellTiter 96® 
nonradioactive cell proliferation assay (Promega, Madison, WI) following the manufacturer’s 
protocol with minor modification as previously described by (Sutherland et al., 2005).  Briefly, 
porcine lymphocytes were used at a concentration of 5  106 cells/mL and placed in triplicate 
into a sterile 96-well flat-bottom plate.  Concanavalin A (CONA; Sigma Aldrich) and 
lipopolysaccharide (LPS; Sigma Aldrich) were used as mitogens (0, 0.2, 2.0 and 20 µg/mL) to 
stimulate T and B cells, respectively. Plates were incubated 68 h at 37oC in a 5% CO2 humidified 
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incubator and 15 µL Promega Dye was added to each well, and the plates were incubated 4 h. 
Promega Stop solution (100 µL) was added, and the plates were incubated overnight at 37ºC and 
then read using a microplate reader (BIO-TEK Instruments) at wavelength 550 nm with 
reference wavelength 690 nm.  The results are expressed as a proliferation index (PI): 
Optical density (550/690 nm) stimulated cells 
PI  = 
   Optical density (550/690 nm) non-stimulated cells 
 
 Natural killer (NK) cell cytotoxicity was measured using a commercially available 
nonradioactive cytotoxicity detection kit (Roche Diagnostics, Indianapolis, IN) as described 
previously by Sutherland et al. (2005).  Briefly, porcine lymphocytes were used as effector cells 
and K-562 chronic human myelogenous leukemia cells (American Tissue Type Culture 
Collection, Manassas, VA) were used as target cells.  Lymphocytes were adjusted to 1 × 
107cells/mL and K-562 cells adjusted to a constant 10,000 cells per well.  Samples were run in 
triplicate at effector (lymphocytes) to target-cell (K-562) ratios of 12.5:1, 25:1, 50:1, and 100:1, 
respectively.  Plates were read using a microplate reader (BIO-TEK Instruments) at wavelength 
490 nm and reference wavelength 690 nm after an 18 h incubation period.  Percent cytotoxicity 
was calculated as described by (Lumpkin and McGlone, 1992) and an assay was considered 
valid if maximum release divided by spontaneous release was ≤20%. 
 
Fecal Enumerations 
Fecal samples were collected on the same days as blood samples.  Yeast enumerations 
were done by standard methods on Rose Bengal Chloramphenicol Agar (Oxoid).  The first 10:1 
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dilution was made by adding 9 volumes Maximum recovery diluent (MRD) of the original 
sample weight. Further serial dilutions were made with MRD (100µl into 900µl) and then plated 
by spread plate method (100µl) onto duplicate agar plates in concentrations of 1 x 101 to 1 x 109.  
The RBC agar plates were incubated aerobically for 3 days at 30 ºC.  After 3 days positive 
identification was based on the typical colony morphology of SCB control strain. Yeast colonies 
were successfully grown on RBC agar streaked with samples collected from only sows in the 
probiotic treatment. This was used to confirm that the control sows did not ingest a significant 
amount of the probiotic to maintain a colony in the GI tract.  Sample pictures of SBC growth on 
RBC agar are shown (Figure 2.), provided by Dr. Ken Mellits at the University of Nottingham. 
Behavioral Measures  
   Behavior of sows was recorded in replicate 1 (n=4) using a Geovision GV-1240 video 
capture combo card and viewed using Window Media Player in real-time.  Behavior was 
recorded continually for 24-h post-farrowing.  Postural (sit, stand, lay), maintenance (eat, drink) 
and oral-nasal-facial (ONF) behaviors were observed and registered.  Also, social interaction 
between sow and piglets were also registered, these included physical contact between sow and 
piglet and nursing bouts (Table 1).  Behaviors were analyzed using continuous sampling.   
Performance Measures 
 Sow BW was recorded on d 84 of gestation and again at weaning.  Piglet BW was 
recorded on d 1, 7, 14, and 21 days of age, and again at 24-h, d 7 and 14 post-weaning.   
 
 
 18 
 
Statistical Analysis 
 Data were analyzed using PROC MIXED with repeated measures SAS (SAS Inst. Inc., 
Cary, NC). All traits were tested for departures from a normal distribution.  The model included 
fixed effects of treatment (control or probiotic) and day of gestation for sows and treatment and 
day of life for piglets.  The random effect of parity was evaluated for sows.  A preliminary 
analysis of data means and numerical trends was used to analyze sow behavior measurements. 
Behavioral observations for replicates 2 and 3 are still in progress, thus, the entire data set is not 
complete yet to do a valid statistical analysis. Estimates were obtained using the PROC MIXED 
of SAS.  Significance was set at (P ≤ 0.05), and trends were discussed at (P ≤ 0.10). 
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RESULTS 
 
Sows -Gestation 
 During gestation, there were no main effects of probiotics on sow immune or endocrine 
traits (Table 2), but there were main effects of day of gestation on immune traits (Figure 3 and 
4). Whole white blood cells stayed consistent throughout gestation while neutrophil and 
lymphocyte populations changed (Figure 3).  Neutrophil count increased between d 105 
(3.6x107) and d 112 (4.4x107) while lymphocytes decreased between d 105 (2.3 x107) and d 112 
(2.0 x107) (Figure 3).  Percentage of lymphocytes decreased while neutrophils increased across 
days of gestation (Figure 4). 
There was a day of gestation x treatment effect on cortisol (Figure 5).  Sows fed the PRO 
bolus had greater (P < 0.05) cortisol on d 98 of gestation than did those sows fed CON bolus.  
Sows –Farrowing and Weaning Stress 
There were treatment effects on several immune and cortisol measures in response to farrowing 
stress (24-h post-farrowing) and weaning stress (Table 3).  At 24-h post farrowing, sows fed 
PRO bolus had greater (P<0.05) total white blood cell and neutrophil counts but less (P < 0.05) 
plasma cortisol compared to those sows fed CON bolus (Table 3 and Figure 6).  At weaning 
sows fed the CON bolus still had greater (P<0.05) plasma cortisol compared to those sows fed 
the PRO bolus.  Moreover, sows fed the PRO bolus had greater (P < 0.01) LPS-induced 
lymphocyte proliferation than did those sows fed CON bolus.  All others traits were similar 
between treatments at both 24-h post-farrowing and weaning (Table 3).   
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Sow Performance  
 Sow body weight and litter weight were similar between sows fed CON and PRO boluses 
(Table 4).   
 
Behavior 
 No significant differences were seen between treatments on post farrow sow behavior 
(Table 5).  This is probably in part to low numbers (n=6).  Apart from this fact there could still 
be a potential that probiotics could affect sow behavior.  The duration of maternal behaviors 
displayed, nursing bout and physical contact with piglets, did not vary by much between 
treatments.  Sows fed the CON bolus spent almost double the amount of time drinking compared 
to sows fed the PRO bolus, but didn’t differ in time spent eating.   Sows fed the CON bolus 
displayed a greater amount of stereotypic oral-nasal-facial behavior compared to sows fed the 
PRO bolus.  Sows fed the PRO bolus tended to display less lay and stand behavior compared to 
sows fed the CON bolus.  Conversely, sows fed the CON bolus tended to display less sit 
behavior compared to sows fed the PRO bolus.   
Maternal Treatment Effects on Offspring During Lactation  
In general there were dam treatment effects on her offspring (Table 6).  Those piglets 
from dams receiving the PRO bolus had less (P<0.05) total plasma cortisol but greater (P < 0.01) 
total white blood cell count and greater (P < 0.01) Interleukin-12 than did piglets from sows fed 
CON bolus.  All other traits were similar between piglets from dams fed either PRO or CON 
boluses.  
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 There was a dam treatment x piglet day age effect on several traits (Table 7).  At birth, 
piglets from dams fed PRO bolus had less (P<0.001) cortisol but greater total WBC (P = 0.32) 
and percent segmented neutrophils (P < 0.05) than did piglets from dams fed CON bolus.  Piglets 
from dams fed PRO bolus tended to have a higher (P<0.10) percentage of monocytes on 
Preprocess, but had less (P<0.05) percentage lymphocytes on post process compared to offspring 
of CON sows (Table 8).  At d 7 of age, piglets from sows fed PRO bolus had greater (P < 0.05) 
total white blood cell and percentage of lymphocytes (P < 0.10), but less (P < 0.05) but less 
segmented neutrophils (Table 7).  At d 14 of age, those piglets from sows fed PRO bolus had 
greater (P < 0.05) neutrophil chemotaxis in response to both IL-8 and C5a and IL-12 compared 
to piglets from sows fed CON bolus (Table 7).  Across all days of age, only IL-12 was affected 
by dam treatment, with those piglets at 14 d of age having greater (P < 0.05) IL-12 than piglets 
from sows fed CON bolus (Table 7).  At d21 of age, those piglets from sows fed PRO bolus had 
less (P < 0.05) lymphocytes but greater (P < 0.10) neutrophil phagocytosis compared to offspring 
of CON sows.  Those piglets from sows fed CON bolus had greater (P<0.05) neutrophil 
chemotaxis in response to IL-8 compared to piglets from sows fed PRO bolus. 
Maternal Treatment Effects on Piglets to Weaning Stress  
 The change in measures of well-being between the 24hr period of weaning and post 
weaning had little effect on immune measures.  In all measures that were effected, the stress of 
weaning seemed to have less of an impact on offspring from sows fed PRO bolus compared to 
those piglets from sows fed CON bolus (Table 9).  Total white blood cell count (P<0.001) and 
percentage of banded neutrophils (P<0.10) were both less for piglets from sows fed PRO bolus 
compared with piglets from sows fed CON.  Although not statistically relevant it is biologically 
relevant that during the weaning processes we saw a change in total lymphocyte count 
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5.16x107in offspring of PRO sows compared to a change of 9.14 x107 in offspring of CON sows 
(Table 9).  
Long-term Maternal Treatment Effects on Piglets (Post Wean) 
Maternal treatment effect on piglets immune traits post-weaning (Table 10).  Total white 
bloods cells, neutrophils, and lymphocytes counts were all lower (P<0.05) while percentages of 
lymphocytes were greater (P < 0.01) and neutrophils less (P <0.01) in offspring from sows fed 
PRO bolus compared to offspring from sows fed CON (Table 10).  Plasma cortisol was greater 
(P<0.05) and NK less (P <0.10) in the offspring from sows fed PRO compared to piglets from 
sows fed CON (Table 10).  
There were maternal treatment effects on piglet immune traits at 24-h post-wean, and 7 and 
14 d post-wean (Table 11).  At 24-h post-wean, piglets from sows fed PRO bolus had less 
(P<0.01) total white blood cell count and neutrophil bands (P<0.10) but greater plasma cortisol 
(P<0.001) compared with piglets from sows fed CON bolus (Table 11).  At d 7 post-wean, 
piglets from sows fed PRO bolus had greater (P < 0.01) percentage of lymphocyte but less (P 
<0.05) NK cytotoxicity than did piglets from sows fed CON bolus.  Percent of eosinophils were 
lower (P<0.05) in those piglets from sows fed CON bolus (0.45%) compared to piglets from 
sows fed PRO (0.93%) (Table 11).  At d 14 post-wean, piglets from sows fed PRO bolus had 
lower total neutrophils (P < 0.001) and lymphocytes (P<0.10) counts and less segmented 
neutrophil (P < 0.01), a greater percentage of lymphocytes (0.01) and greater (P<0.05) neutrophil 
chemotaxis in response to both IL-8 than did piglets from sows fed CON bolus (Table 11).   
Piglet weight and levels of Interleukin-12 did not vary between treatment throughout the 
whole trial (Figure 7 and 8). 
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DISCUSSION 
 
Feeding yeast-derived probiotic boluses to sows during gestation and lactation can affect 
the physiology of both dams and her piglets.  An increase in total white blood cell count was 
found for sows that consumed probiotic bolus.  Positive effects of probiotics were also found in 
plasma cortisol levels.  During the weaning process sows fed CON tended to have a higher 
cortisol reading than sows fed PRO.  Control sows were always bled first, and blood was not 
taken from the sow until her own litter had been removed from the pen.  Sows were kept in one 
single room so there possibility remains that some sows were stressed out from the general 
commotion of the weaning process before her own litter was even removed.  IF, the probiotic fed 
sows, always bled proceeding control fed sows, were affected by this commotion we would 
expect cortisol to already be elevated in the blood system and for levels to be skewed.  If this was 
the case, we may have hindered the results from displaying even a bigger gap of cortisol levels 
between treatments. 
Probiotics affected the physiology of both dams and her piglets.  An increase in total 
white blood cell count was found for sows that consumed probiotic bolus and this resulted in 
their offspring also having higher total WBC count.  Moreover, post-weaning, piglets from sows 
fed the CON bolus had lower total white blood cell count than piglets of sows fed the PRO 
bolus. The increase in the total number of white blood cells in the periphery may be indicative of 
an activated immune system in response to the effects of probiotics.  On d7, cell populations 
were affected by probiotic supplementation with lymphocytes being higher and segmented 
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neutrophils were lower (matured banded neutrophils) in the blood of piglets of sows fed PRO 
compared to piglets of sows fed CON.  
Cortisol levels of piglets at birth showed an as interesting picture.  Offspring of sows fed 
the CB had a cortisol mean level of 203.55pg/mL compared to of those offspring of sows fed the 
PB, 129.77pg/mL.  Sows were observed 24/7 around farrowing and when a piglet was born, they 
were immediately dried off and bled, preventing any outside influences on cortisol level.   
It appears that farrowing is more of a humoral driven stress response and weaning is 
more of a “cell-mediated” driven stress response.  This is explained by the day effect of IL-12 
plasma concentrations tending to be at significantly higher levels on weaning compared to 24h 
post farrowing.  Interleukin-12 is a cytokine produced by the TH1 T-cell subset.  IL-12 produces 
cytokines that activate macrophages enabling them to destroy intracellular microorganisms as 
well as activate b-cells to produce strong antibodies.  This is known as a cell-mediated response.  
Offspring of the sows fed PRO also had higher levels of IL-12 compared to their counter parts.  
This could potentially be attributed to their maternal transfer across the GI tract occurring though 
the dam’s milk allowing for the passage of IL-12 from dam to piglet.  On the contrary, Gad et al 
found that S. boulardii was unable to stimulate cytokines like IL-12.  The TH1 subset also 
contains the Interleukin, IL-10.  This interleukin is produced by lactic acid bacteria (LAB).  This 
LAB has the ability to secrete suppressive cytokines like IL-10.  When probiotics increase the 
production of LAB, it would cause the decrease the dendritic cell activation (De Moreno de 
LeBlanc et al., 2008).  A clear example of this effect can be seen on PreWean of the piglets of 
sows fed CON with a higher amount of migrated cells by the chemokine IL-8 than the off spring 
of sows fed PRO.  The immune response of phagocytosis by neutrophils is also suppressed.  
Piglets of sow fed CON are less successful at engulfing the florescent beads compared to the 
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offspring of pigs fed PRO.  Although this is a suppression of the immune system, it could be a 
positive benefit to a young piglet.  Early in life a piglet’s immune system is very naïve, the 
immune system is put into gear sometimes too quickly.  Dalmasso et al, (2006) found that an 
over-stimulation of the inflammatory response can lead to chronic systems such as IBS.  Thus 
this suppression allows the piglet’s immune system to stay in a more stable state and not become 
potentially hypersensitive to stress.   
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IMPLICATIONS 
 
According to Bauer et al. (2006), it takes usually about seven weeks for the intestinal 
composition to be comparable to that of a mature animal.  Probiotics enhanced the sow’s 
immune system.  From the data we assume that the difference in immune measures is related to 
the maternal transfer and the indirect effects of probiotics on the dam’s immune system.  In light 
of this, the immune system may have been statistically different between treatments for immune 
and endocrine measures but performance measures did not vary.  If neither treatment of piglets 
are able to cope with the various stressors that they encounter in the first few weeks of life, then 
the response may not vary as much.  Probiotics that are directly fed to piglets help assist in this 
process, by protecting the intestinal population of good bacteria/yeast by amping up the 
population numbers.  Since the maternal transfer benefits, not the direct feeding of probiotics, 
was the focus of the study to offspring, we may not experience such an extreme degree of 
difference as hoped for.  In order to get a more holistic picture of the effects of probiotics, more 
performance and productivity measures should be evaluated.  The following are suggestions for 
further investigation; more frequent weight measurements of sows during gestation, feed intake 
of sows during farrowing, standardized litters, the evaluation of various interleukins found in 
dam’s colostrum, and the administration of an immune challenge by the inoculation 
administration of E-Coli or LPS (lipopolysaccharide). 
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(Lomax et al., 2009)  Bacteriocins are produced by bacteria to inhibit the growth of similar or closely related bacterial 
strain.  Produced by Lactobacillus and other species which produce lactic acid. 
FIGURES AND TABLES 
 
 
 
 
 
Figure 1. Probiotic’s Effect on the Gastrointestinal System 
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Figure 2. A Breakdown of the Immune System: Acquired verses Innate 
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Figure 3. TH1 and TH2 Driven Immunity 
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Figure 4a.  Process of Lymphocyte/Neutrophil Separation from Whole Blood 
 
 
 
 
 
 
 
 
 
  
 31 
 
Figure 4b.  Diagram of Leukocyte Subpopulations in a Blood smear 
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Figure 5.  S. boulardii Positive Colonies on Rose Bengal Chloramphenicol Agar 
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Figure 6. Effect of day of gestation on sow total white blood cell, neutrophil and 
lymphocyte counts (least squares means ± SE).  
Least square means do not differ between days of gestation for total white blood cell count and neutrophil 
count.  D91 and d112 for Lymphocytes differ (P<0.05), all other days do not differ.  
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Figure 7. Effect of day of gestation on percentage of neutrophils and lymphocytes (least 
squares means)  
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Figure 8.  Effect of treatment by day of gestation on plasma cortisol (least squares means ± 
SE)  
    
*within a day, means differ (P < 0.10) 
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Figure 9. Effects of treatment on sow plasma cortisol levels in response to farrowing stress 
(24-h post farrowing) and weaning stress (least squares means ± SE) 
 
 
 
a,b within a day, means without a common superscript differ (P<0.05) 
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Figure 10.  Day of life and maternal diet treatment effects on piglet weight (least squares means ± SE) 
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Figure 11.  Maternal diet treatment effects by piglet day of age on plasma Interleukin-12 levels (least squares means ± SE) 
 
*  within a day, means differ (P<0.05)   
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Table 1.  Definitions of Registered Behaviors  
 
 
 
 
 
  
Behavior Description 
 
Oral-nasal-facial Snout/mouth in contact with any object other than feeder when feed is 
present 
Sham-chew Continuous chewing in absence of feed or substrate 
 
Sit 
 
Body supported primarily by rump and hind legs with front legs 
extended 
Stand Body positioned upright  with all four limbs and hooves in contact with 
floor 
 
Lay 
 
Not supported by any limbs. Full contact with ground  
 
Eat 
 
Feed present and head is in or over feed trough 
 
Drink 
 
Nest Building 
 
 
Physical Contact 
with piglet 
 
Nursing Bout 
 
Stationary contact with snout/mouth to nipple waterer 
 
Not a chewing action but pulling at the feeder or bars with mouth and/or 
pawing at the ground with hooves (ie, digging) 
 
Contact of the head of the sow to the head of a piglet or head of sow to 
body of piglet 
 
Piglet’s snouts and mouths in contact with sow’s udder/teats while 
exhibiting rhythmic suckling; must be the majority of piglets of a litter 
(more than 75%) 
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Table 2.  Effects of treatment on sow immune and endocrine traits across gestation (least 
squares means ± SE) 
 Treatment  
Measure Control Probiotic P-value 
Total WBC, 107 2.8 ± 0.13  2.3 ± 0.13 0.268 
Lymphocyte, 107 2.5 ± 0.17 2.5 ± 0.17 0.457 
Neutrophil, 107 4.1 ± 0.50 3.6 ± 0.50 0.979 
Lymphocytes, % 56.5 ± 2.0 52.9 ± 2.0 0.204 
Eosinophils, % 5.4 ± 0.85 6.3 ± 0.85 0.963 
Segmented neutrophils, % 32.4 ± 1.9 34.6 ± 1.9 0.426 
Banded neutrophils, % 2.3 ± 0.82 2.2 ± 0.82 0.931 
Phagocytosis, % 54.4 ± 2.3 55.3 ± 2.3 0.777 
Chemotaxis, C5a 7.0 ± 3.3 11.4 ± 3.2 0.606 
Chemotaxis, IL8 10.6 ± 9.7 18.0 ± 9.3 0.584 
Cortisol, ng/mL 35.1 ± 3.5 39.5 ± 3.4 0.376 
Interleukin-12 pg/mL 187.7 ± 14.8 195.1 ± 14.8 0.723 
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Table 3. Effects of treatment on sow immune and endocrine traits in response to farrowing 
stress (24-h post farrowing) and weaning stress (least squares means ± SE). 
 24hr post-farrow Wean 
Measure Control Probiotic Control Probiotic 
Total WBC, 107 1.35 ± 0.3* 2.35 ± 0.3 2.0 ± 0.3 2.34 ± 0.3 
Lymphocyte, 107 1.9 ± 0.4 2.20± 0.3 2.30± 0.3 1.64 ± 0.3 
Neutrophil, 107 2.9 ± 0.4* 4.35 ± 0.4 3.54 ± 0.4 3.52 ± 0.4 
Lymphocytes, % 41.8 ± 5.0 45.7 ± 5.0 44.20 ± 5.4 52.4 ± 5.0 
Banded neutrophils, % 11.9 ± 3.8 12.0 ± 3.8 1.77 ± 4.2 2.18 ± 3.8 
Segmented neutrophils, % 40.1 ± 4.6 33.7 ± 4.6 46.1 ± 5.0 37.0 ± 4.6 
Interleukin-12 pg/mL 141.4 ± 21.7 137.6 ± 21.0 204.9 ± 20.0 221.3± 20.0 
Cortisol ng/mL 102.6 ± 9.01* 63.4 ± 8.28 66.6 ± 8.3* 40.0 ± 8.7 
LPS-induced proliferation 02 1.45 ± 0.25 1.81 ± 0.21 1.62 ±0.09*  1.0 ± 0.10 
ConA-induced proliferation 02 1.05 ± 0.06 1.15 ± 0.05 1.10 ±0.38 1.64 ± 0.38 
NK cytotoxicity, % 12.5:1 . . 78.23 ± 16.8 85.2 ± 16.8 
Phagocytosis, % 60.41 ± 6.0 58.60± 5.8 54.10 ± 5.8 53.40 ± 5.5 
*within a day, means differ (P<0.05).   
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Table 4. Effects of diet on sow performance traits (least squares means ± SE) 
 Dietary Treatment  
Measure Control Probiotic P-value 
Starting sow body weight 225.2 ± 7.7 224.4 ± 7.7 0.993 
Ending  sow body weight 219.5 ± 7.7 215.7 ± 7.7 0.676 
Piglets born alive 11.89 ± 0.9 12.56 ± 0.9 0.612 
Piglets weaned 10.44 ± 0.9  10.56 ± 0.9 0.932 
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Table 5. Effect of treatment on Post-farrow sow behavior (least squares means ± SE) 
Behavior (min) Control Probiotic P- Value 
Lay 1342.2 ± 16.3 1324.1 ± 20.0 0.533 
Stand 64.4 ± 10.5 41.5 ± 12.8 0.26 
Sit 28.5 ± 25.6 69.1 ± 31.4 0.39 
Drink 13.5 ± 5.7 7.10± 7.0 0.53 
Eat 10.9 ± 6.7 10.3 ± 8.14 0.96 
ONF 19.0 ± 4.4 7.1 ± 5.4 0.18 
Physical Contact 31.0 ± 6.4 24.9 ± 7.9 0.59 
Nursing Bout 41.7 ± 16.9 48.8 ± 20.6 0.81 
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Table 6.  Dam treatment effect on her offsprings’ immune response during lactation (least 
squares means ± SE) 
Measure Control Probiotic P-value 
Total WBC, 107 3.0 ± 0.1a 3.5 ± 0.1b 0.02 
Lymphocyte, 107 6.0 ± 0.8 4.6 ± 0.8 0.24 
Neutrophil, 107 3.0 ± 0.2 2.7 ± 0.2 0.78 
Lymphocytes, % 47.3 ± 1.0 45.8 ± 1.1 0.32 
Segmented neutrophils, % 49.1 ± 1.0 50.3 ± 1.0 0.36 
Cortisol ng/mL 71.2 ± 2.9a 62.8 ± 2.9b 0.04 
Interleukin-12 pg/mL 212.9  ± 9.0c 235.0 ± 8.8d 0.079 
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Table 7.  Effects of sow treatment and age of piglet on piglet immune and endocrine traits (least squares means ± SE) 
 Birth D7 D14 D21 
Measure Control Probiotic Control Probiotic   Control Probiotic 
Total WBC, 107 1.6 ± 0.5 2.3 ± 0.4 6.7 ± 0.4a 8.0 ± 0.4b 3.3 ± 0.3 3.1 ± 0.3 1.9 ± 0.3 2.5 ± 0.3 
Lymphocyte, 107 . . 4.2 ± 1.4 3.4 ± 1.5 2.8 ± 1.4 4.0 ± 1.4 10.9 ± 1.4a 6.4 ± 1.4b 
Neutrophil, 107 . . 4.3 ± 0.4 3.7 ± 0.4 2.3 ± 0.4 2.6 ± 0.4 2.4 ± 0.4 2.0 ± 0.4 
Lymphocytes,% 44.3 ± 3.5 39.4 ± 3.5 46.1 ± 2.1c 52.1 ± 2.3d 60.9 ± 2.2 64.2 ± 2.2 66.4 ± 2.2 64.4 ± 2.2 
Seg. Neutrophils,% 49.2 ± 3.3a 58.7 ± 3.3b 50.4 ± 2.0a 42.5 ± 2.2b 37.0 ± 2.1 32.7 ± 2.1 31.9 ± 2.1 33.0 ± 2.1 
Cortisol ng/mL 203.6±10.0a 129.8±8.2b 42.6 ± 6.3 42.2 ± 6.5 40.2 ± 6.5 50.5 ± 6.6 45.4 ± 6.6 48.4 ± 6.5 
Chemotaxis, C5a . . 11.8 ± 5.3 13.9 ± 6.5 18.06 ± 4.7a 32.3 ± 4.5b 27.8 ± 6.3 28.6 ± 5.8 
Chemotaxis, IL8 . . 13.9 ± 8.0 11.7 ± 9.1 25.1 ± 6.3a 42.7 ± 5.7b 36.9 ± 7.4c 18.2 ± 7.8d 
Phagocytosis, % . . 66.4 ± 2.1 66.4 ± 2.5 65.1 ± 2.1 61.5 ± 2.2 55.7 ± 2.2c 61.2 ± 2.2d 
Interleukin-12pg/mL 169.0±31.6 180.0±26.6 166.3±18.8 158.1±19.9 262.9±18.6a 319.5±19.4b 297.6±19.9 316.1±19.4
a,b if treatments vary between days p<0.05, c,d if they vary P<0.10 
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Table 8. Effects of sow treatment on piglet immune response on Pre and Post Process (least 
squares means ± SE) 
 Pre Process Post Process 
Measure Control Probiotic Control Probiotic 
Total WBC, 107 2.3 ± 0.3 2.7 ± 0.3 2.0 ± 0.3 2.4 ± 0.3 
Lymphocytes, % 28.4 ± 2.4 24.9 ± 2.7 37.4 ± 2.2a 29.8 ± 2.6b 
Banded neutrophils, % 2.9 ± 0.6 2.3 ± 0.7 1.4 ± 0.6c 3.0 ± 0.7d 
Segmented neutrophils, % 66.6 ± 2.3 69.6 ± 2.6 59.3 ± 2.1c 65.6 ± 2.5d 
Monocytes, % 1.5 ± 0.3c 2.4 ± 0.4d 1.5 ± 0.3 1.4 ± 0.4 
Eosinophils, % 0.72 ± 0.1a 0.36 ± 0.1b 0.07 ± 0.1 0.24 ± 0.1 
Interleukin-12 pg/mL 196.2 ± 20.3 228.2 ± 22.0 185.5 ± 19.9 208.0 ± 20.6
Cortisol ng/mL 35.7 ± 6.6 37.5 ± 7.1 59.9 ± 6.4 68.3 ± 6.7 
a,b if treatments vary between days p<0.05, c,d if they vary P<0.10 
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Table 9.  Change of piglet immune and endocrine traits during weaning (least squares means ± SE) 
 PreWean Post Wean ∆ in measures within 
TRT 
Measure Control Probiotic Control Probiotic Control Probiotic 
Total WBC, 107 2.0 ± 0.3 2.5 ± 0.3 2.1 ± 0.2 1.3 ± 0.2 1.8 ± 0.1a 0.9 ± 0.1b 
Lymphocyte, 107 10.9 ± 1.4 6.4 ± 1.4 2.2 ± 0.3 1.5 ± 0.3 9.1 ± 2.8 5.2 ± 2.2 
Neutrophil, 107 2.4 ± 0.4 2.0 ± 0.4 1.56 ± 0.4 2.03 ± 0.4 1.8 ± 0.7 1.8 ± 0.6 
Lymphocytes, % 66.4 ± 2.1 64.4 ± 2.2 55.4 ± 2.0 56.4 ± 2.1 15.0 ± 1.8 14.9 ± 1.8 
Segmented neutrophils, % 49.2 ± 3.3 58.7 ± 3.3 41.4 ± 2.0 40.6 ± 2.0 13.7 ± 1.7 14.4 ± 1.8 
Banded neutrophils, % 0.15 ± 0.6 0.38 ± 0.6 0.63 ± 0.1 0.33 ± 0.1 0.77 ± 0.1c 0.36 ± 0.2d 
Phagocytosis, % 55.7 ± 2.2 61.2 ± 2.2 68.3 ± 2.2 63.6 ± 2.3 25.9 ± 3.6 18.9 ± 3.6 
Cortisol ng/mL 71.2 ± 3.0 62.8 ± 2.8 36.0 ± 3.2 52.0 ± 3.2 19.4 ± 3.6 23.4 ± 3.4 
Interleukin-12 pg/mL 297.6 ± 19.9 316.1 ± 19.6 226.7 ± 23.5 252.9 ± 24.0 97.43 ± 19.5 121.7 ± 19.2
a,b if ∆ in least squared means differ between treatments  (P<0.05), c,d if they differ (P<0.10) 
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Table 10.  Overall Maternal diet treatment on piglet immune and endocrine response post 
weaning (24-h post wean to PTW14) (least squares means ± SE) 
Measure Control Probiotic P-value 
Total WBC, 107 2.5 ± 0.2 1.3 ± 0.2  0.042 
Lymphocyte, 107 3.2 ± 0.2 2.5 ± 0.2 0.007 
Neutrophil, 107 3.9 ± 0.3 3.0 ± 0.2 0.014 
Lymphocytes, % 53.9 ± 1.3 58.6 ± 1.3 0.009 
Segmented neutrophils, % 42.8 ± 1.3 37.8 ± 1.3 0.005 
Cortisol ng/mL 29.7 ± 2.2 36.3 ± 2.1 0.032 
NK cytotoxicity, % 25:1 95.6 ± 4.3 85.2 ± 4.3 0.087 
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Table 11.  Maternal treatment and age of piglet effects on piglet immune and endocrine traits post-weaning (least squares 
means ± SE) 
 24h Post Wean PTW7 PTW14 
Measure Control Probiotic Control Probiotic Control Probiotic 
Total WBC, 107 2.1 ± 0.2a 1.3 ± 0.2b 3.4 ± 0.2 3.4 ± 0.2 2.2 ± 0.2 2.10± 0.2 
Lymphocyte, 107 2.2 ± 0.3 1.5 ± 0.3 4.5 ± 0.4 3.6 ± 0.4 3.1 ± 0.3c 2.5 ± 0.3d
Neutrophil, 107 1.6 ± 0.4 2.0 ± 0.4 7.7 ± 0.5 4.8 ± 0.5 2.3 ± 0.4a 2.1 ± 0.4b
Lymphocytes, % 55.4 ± 2.0 56.4 ± 2.1 58.8 ± 2.0a 60.9 ± 2.0b 47.5 ± 2.6 a 58.6 ± 2.6b  
Segmented neutrophils, % 41.4 ± 2.0 40.6 ± 2.0 49.9 ± 2.5 38.6 ± 2.5 37.3 ± 2.0a 34.2 ± 2.0b
Banded neutrophils, % 0.63 ± 0.1c 0.33 ± 0.1d 0.03 ± 0.2 0.34 ± 0.2 0.30 ± 0.1 0.30 ± 0.1 
Eosinophils, % 0.35 ± 0.1 0.24 ± 0.1 0.47 ± 0.1a 0.94 ± 0.1b 0.9 ± 0.2 0.83 ± 0.2 
Chemotaxis, IL8 28.5 ± 4.4 21.8 ± 5.7 29.9 ± 5.4 16.1 ± 6.2 14.1 ± 4.4c 17.0 ± 3.2d 
NK cytotoxicity, % 50:1 92.5 ± 10.6 89.1 ± 11.0 . . . . 
NK cytotoxicity, % 25:1 67.4 ± 9.0 60.4 ± 9.3 86.4 ± 9.9c 76.3 ± 6.8d . . 
NK cytotoxicity, % 12.5:1 43.2 ± 6.8 41.2 ± 7.0 49.3 ± 5.2 a 44.4 ± 5.1b 86.6 ± 4.6 71.7 ± 4.9 
Cortisol ng/mL 36.0 ± 3.2a 52.0 ± 3.2b 26.7 ± 4.3 24.8 ± 4.3 26.5 ± 3.8 32.2 ± 3.5 
Within a day, means differ (P<0.05).  A,b if treatments vary between days p<0.05, c,d if they vary P<0.10
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